# Mineralys Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Mar 17, 2025

- Company: [Mineralys Therapeutics, Inc.](/companies/mlys.md) (CIK 1933414)
- Form: SCHEDULE 13D/A
- Filed: 2025-03-17
- Accepted by EDGAR: Mar 17, 2025, 21:06 ET
- Period: not reported
- Accession: 0001415889-25-008276
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1933414/000141588925008276/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1933414/000141588925008276/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1933414/000141588925008276/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001415889-25-008276. Last ingested by Listed: Oct 29, 2026, 16:10 ET. No prices; not investment advice.